FolioLanternBeta
ABTAbbott Laboratories

Louis Morrone

Executive Vice President at Abbott Laboratories, as of Aug 13, 2026Sold $775K of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
11%
share of stake sold at Abbott Laboratories
71K
shares held after the latest filing, Abbott Laboratories
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $132K no plan disclosedMarAprMayJunJulAug 2026: $643K no plan disclosed$643KAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Abbott Laboratories (ABT)Executive Vice PresidentJul 6, 2021Aug 13, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.